Thomas M. Cardillo

Researcher Thomas M. Cardillo discusses the synergistic anti-tumor effects of Sacituzumab Govitecan with platinum-based chemotherapy in inhibiting cancer cell growth. They explore significant tumor regressions in mice tumor models, showing promise for clinical investigation in solid tumor treatment revolution.

Researchers discuss the significant antitumor effects of combining Sacituzumab govitecan with platinum-based chemotherapy in triple-negative breast, urinary bladder, and small-cell lung carcinomas. Promising results are seen in mouse models with this combination treatment.